Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats
- 1 February 1999
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 367 (2-3) , 255-265
- https://doi.org/10.1016/s0014-2999(98)00983-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- IrbesartanDrugs, 1997
- A new formalin test allowing stimulaneous evaluation of cardiovascular and nociceptive responsesCanadian Journal of Physiology and Pharmacology, 1997
- Pharmacokinetic-Pharmacodynamic Profile of Angiotensin II Receptor AntagonistsClinical Pharmacokinetics, 1997
- Angiotensin Receptors in the BrainBasic & Clinical Pharmacology & Toxicology, 1995
- Hemodynamic and Biochemical Effects of the AT 1 Receptor Antagonist Irbesartan in HypertensionHypertension, 1995
- Repeated measurements and multiple comparisons in cardiovascular researchCardiovascular Research, 1994
- Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats.Hypertension, 1992
- Mapping of angiotensin II receptor subtype heterogeneity in rat brainJournal of Comparative Neurology, 1992
- Projections from the subfornical organ to the supraoptic nucleus in the rat: ultrastructural identification of an interposed synapse in the median preoptic nucleus using a combination of neuronal tracersBrain Research, 1991
- Organization of Angiotensin II Immunoreactive Cells and Fibers in the Rat Central Nervous SystemNeuroendocrinology, 1985